OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
July 03, 2022
Lack of toxicity data and poor physicochemical properties must be overcome.
Demand spurs innovations in syringes and syringe fill/finish operations.
July 02, 2022
By understanding potential material change, the impact on patient safety can be understood and mitigated.
As a result of the disruptions caused by the COVID-19 pandemic, global arbitration has adapted to a ‘new normal’.
A new strategy aims to bring in legislative reforms that will impact medicinal product regulation within Europe.
Agency leaders are moving to develop a rating system to identify those drug manufacturers with more dependable production operations.
Pharma should expand on successful cell therapies in oncology by applying these development and manufacturing methods to neuronal cell therapies.
As we reach further afield in the molecular universe, we encounter new types of problems to resolve.
An SOP for electronic-records archiving is a regulatory requirement and good for business, says Siegfried Schmitt, vice president, Technical at Parexel.
Dame Deborah James’ legacy and the millions raised through her campaigning will undoubtedly be a big boost to clinical research, ultimately providing new and promising treatments for bowel cancer patients.